KBMO Diagnostics
- Company typePrivate
- Founded-
- HeadquartersHopedale, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
KBMO Diagnostics firmographics
Firmographics- Name
- KBMO Diagnostics
- Legal name
- KBMO Diagnostics LLC
- Website
- https://kbmodiagnostics.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where KBMO Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Hopedale
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
KBMO Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Diagnostic Testing Services: Laboratory testing services ordered by healthcare practitioners for their patients. Practitioners purchase test kits and submit samples for analysis, with results delivered through a practitioner portal.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
KBMO Diagnostics product offering
Product offeringCore offering
KBMO Diagnostics provides laboratory diagnostic testing services focused on food sensitivities, gut barrier function, metabolic function, and environmental toxin exposure. Its flagship Food Inflammation Test (FIT) measures both IgG antibodies and complement antigen (C3d) to identify patient food reactivity more accurately than IgG-only tests. The company sells these tests to healthcare practitioners (functional medicine doctors, naturopaths, chiropractors, nutritionists) who administer them to their patients, with samples collected at home via bloodspot or urine kits and results delivered through a dedicated practitioner portal.
Product overview
KBMO Diagnostics offers a portfolio of five diagnostic tests designed for practitioners in functional and integrative medicine. The core offering is the Food Inflammation Test (FIT), which uses a proprietary method detecting both IgG antibodies and complement antigen (C3d) for heightened accuracy. This is complemented by the Gut Barrier Panel (GBP) for intestinal permeability assessment, the Organic Acids test (MIP/Metabolic Insights Profile) for comprehensive metabolic analysis via urine, the Glyphosate Exposure Test for environmental toxin screening, and the Cardiovascular Inflammation Test (CIT) for cardiac-related inflammation markers. The product ecosystem includes a practitioner portal for result access, sample collection kits (bloodspot and urine), educational webinars, podcasts, and practitioner protocols in partnership with supplement brands.
Differentiator
Problem solved
Functional benefit
Products and services
- Food Inflammation Test (FIT) A proprietary food sensitivity blood test that detects both IgG antibodies and complement antigen (C3d) to determine patient reactivity to foods more accurately than IgG-only tests; delivered with color-coded results and a weekly rotation diet plan to support personalized elimination protocols. Designed for functional medicine practitioners, naturopaths, chiropractors, and nutritionists treating patients with chronic inflammatory, digestive, and autoimmune conditions.
- Gut Barrier Panel (GBP) A diagnostic panel that measures intestinal permeability and gut barrier function to identify leaky gut syndrome and related conditions, often paired with the FIT test. Intended for healthcare practitioners managing patients with digestive complaints, chronic inflammation, and autoimmune conditions.
- Organic Acids / Metabolic Insights Profile (MIP) A urine-based organic acids test providing a comprehensive metabolic snapshot including energy production pathways, detoxification markers, microbiome activity, neurotransmitter metabolism, and nutritional status. Used by functional medicine practitioners to evaluate metabolic function in patients with chronic health complaints.
- Glyphosate Exposure Test A diagnostic test measuring patient exposure to glyphosate herbicide to help practitioners assess environmental toxin burden. Designed for healthcare providers evaluating patients with suspected environmental toxin-related health issues.
- Cardiovascular Inflammation Test (CIT) A bloodspot diagnostic test assessing cardiovascular-related inflammation markers to support practitioners in identifying inflammation-driven cardiac health risks. Intended for healthcare providers screening patients for cardiovascular inflammation.
Quantifiable outcome
- 99% of musculoskeletal aches and pains resolved within days of dietary changes based on test results
- +3 more outcomes
Companies that use KBMO Diagnostics
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles1 record
KBMO Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
KBMO Diagnostics partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- FullscriptcoreIntegration with Fullscript supplement dispensing platform enables practitioners to prescribe recommended supplements directly through the KBMO ordering system. Partnership provides convenient platform for prescribing, dispensing, and managing healthcare supplements alongside diagnostic test results.
- NutriDynminorProvides recommended supplement protocols using NutriDyn products based on test results. Offers downloadable protocol guides for practitioners.
- Biotics Research CorporationminorProvides recommended supplement protocols using Biotics Research products based on test results. Offers downloadable protocol guides for practitioners.
- Microbiome ResearchminorProvides gut health and microbiome support protocols complementary to FIT and GBP test results.
Scale indicators1 record
Expansion highlights1 record
KBMO Diagnostics competitors and assessment
Company assessmentDirect peers
- Genova Diagnostics: Specialty clinical laboratory offering food sensitivity, gut, metabolic, and hormone panels to functional and integrative medicine practitioners — the closest comparable by test menu and channel.
- Vibrant Wellness: Specialty lab running food sensitivity, gut, and environmental panels sold B2B to practitioners; competes head-to-head with KBMO on the FIT-style food reactivity panel.
- Cyrex Laboratories: Array-based specialty lab focused on food sensitivities, gluten, and autoimmunity panels marketed to functional medicine providers — a near-direct competitor in the same practitioner channel.
- Mosaic Diagnostics (formerly Great Plains Laboratory): Direct-to-practitioner specialty lab with overlapping organic acids, gut, and environmental exposure testing; directly comparable on test menu and functional medicine GTM.
- US BioTek: Specialty lab providing IgG-based food sensitivity panels to integrative and functional medicine practitioners — a direct IgG food testing competitor.
- Alletess Medical Laboratory: Specialty clinical lab focused on food allergy and sensitivity testing sold to healthcare practitioners, overlapping directly with KBMO's flagship FIT.
- Doctor's Data: Specialty clinical lab offering stool, organic acids, toxic element, and other functional medicine panels; competes in overlapping use cases via the same practitioner channel.
- Precision Point Diagnostics: Practitioner-focused specialty lab offering IgG food sensitivity and gut panels — directly comparable in test menu and B2B channel.
Broad incumbents
- Quest Diagnostics: Large national reference laboratory with broad food allergy and immunology testing capability; relevant as a large incumbent that could expand into specialty functional medicine panels.
- Labcorp: National reference lab offering allergy and immunology panels through physician channels; a broad incumbent whose entry into functional-medicine-style testing could pressure specialty labs like KBMO.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights6 records
Customer concentration
KBMO Diagnostics social profiles
Digital presenceKBMO Diagnostics compliance and trust
Trust signalCompliance2 records
KBMO Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
KBMO Diagnostics leadership team
Management profileNumber of profiles
Profiles1 record
KBMO Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KBMO Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KBMO Diagnostics
What does KBMO Diagnostics do?
KBMO Diagnostics provides laboratory diagnostic testing services focused on food sensitivities, gut barrier function, metabolic function, and environmental toxin exposure. Its flagship Food Inflammation Test (FIT) measures both IgG antibodies and complement antigen (C3d) to identify patient food reactivity more accurately than IgG-only tests. The company sells these tests to healthcare practitioners (functional medicine doctors, naturopaths, chiropractors, nutritionists) who administer them to their patients, with samples collected at home via bloodspot or urine kits and results delivered through a dedicated practitioner portal.
When was KBMO Diagnostics founded?
KBMO Diagnostics was founded in -1. It employs 11 to 50 people.
Where is KBMO Diagnostics based?
KBMO Diagnostics is headquartered in Hopedale, United States, in the North America region.
How does KBMO Diagnostics make money?
One revenue line is on record: diagnostic Testing Services.
Who are KBMO Diagnostics's main competitors?
Direct peers on record are Genova Diagnostics, Vibrant Wellness, Cyrex Laboratories, Mosaic Diagnostics (formerly Great Plains Laboratory), US BioTek, Alletess Medical Laboratory, Doctor's Data and Precision Point Diagnostics. Broad incumbents are Quest Diagnostics and Labcorp.
Does KBMO Diagnostics have an API?
No public API is recorded for KBMO Diagnostics.